Market Tracker

04/28 5:16pm ET

ImmunoCellular Therapeutics Ltd (NYSE MKT LLC:IMUC)

2.35
Delayed Data
As of Apr 28
 -0.05 / -2.08%
Today’s Change
1.83
Today|||52-Week Range
12.39
+14.63%
Year-to-Date
3 Different Companies, 3 Different Approaches to Tumors
Apr 24 / GuruFocus News - Paid Partner Content
3 Different Companies With 3 Different Approaches to Tumors
Apr 24 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close2.40
Today’s open2.40
Day’s range2.31 - 2.48
Volume36,896
Average volume (3 months)127,990
Market cap$8.1M
Dividend yield--
Data as of 3:59pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)-31.50%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.32

Competitors

 Today’s
change
Today’s
% change
BASIBioanalytical System...-0.03-2.40%
ABACAoxin Tianli Group I...-0.04-2.63%
YTENYield10 Bioscience I...+0.14+31.23%
FSIFlexible Solutions I...-0.10-6.02%
Data as of 4:00pm ET, 04/28/2017

Financials

Last reporting dateMarch 9, 2017
EPS forecast (this quarter)-$1.20
Annual revenue (last year)$0.00
Annual profit (last year)-$22.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Secretary
Gary S. Titus
President, Chief Executive Officer &
Director
Anthony J. Gringeri
Corporate headquarters
Calabasas, California

Forecasts